MedTrace Logo

Long-limb or Distal Gastric Bypass for Superobesity - Randomized Study

NCT00821197 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2021-09-05

No results posted yet for this study

Summary

The main study objective:

To evaluate long-limb gastric bypass (150 cm alimentary limb) vs. "distal" gastric bypass (common channel 150 cm) in the treatment of superobesity (BMI 50-60 kg/m2).

The main study hypothesis:

Distal bypass accomplish an estimated 10-20 % larger weightloss than long-limb gastric bypass 1 year after surgery. Patients subject to distal bypass have more gastrointestinal side effects and more extensive nutritional deficiences compared to long-limb gastric bypass.

Conditions

Interventions

PROCEDURE

long-limb gastric bypass

Laparoscopic long-limb gastric bypass (150 cm alimentary limb, 50 cm biliopancreatic limb)

PROCEDURE

distal gastric bypass

Laparoscopic distal gastric bypass (150 cm common channel, 50 cm biliopancreatic limb)

Sponsors & Collaborators

  • The Hospital of Vestfold

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Tom Mala MD, PhD Rune Sandbu, MD, PhD · Aker University Hospital / The Hospital of Vestfold

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2015-05-31
Completion
2025-05-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00821197 on ClinicalTrials.gov